Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-74.20	0.37	1.41
Graham Fair Price	41.42	1.90	1.35
PEG	-80.82	0.01	-0.05
Price/Book	-14.91	0.36	0.42
Price/Cash Flow	-57.23	2.72	6.35
Prices/Earnings	-57.46	1.02	2.40
Price/Sales	-57.46	0.37	0.87
Price/FCF	-57.23	2.72	6.35
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.24	0.24
Operating Margin	11.38	0.12	0.10
ROA	100.00	0.05	0.02
ROE	0.04	0.09	100.00
ROIC	0.03	0.06	115.73
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.13	-0.17	-21.10
Dividends QOQ	< 0.005	< 0.005	< 0.005
EBIT QOQ	-0.60	1.23	105.38
EPS QOQ	-0.46	1.02	121.78
FCF QOQ	-0.72	0.99	38.08
Revenue QOQ	-0.58	1.00	73.56
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	98.59	49.29	-50.00
Days Sales Outstanding (DSO)	48.25	27.53	-42.95
Inventory Turnover	0.91	1.83	100.00
Debt/Capitalization	0.24	0.27	9.76
Quick Ratio	1.29	1.35	4.62
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.36	1.36	< 0.005
Cash	0.94	0.95	1.09
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	0.09	0.18	98.92
Revenue	0.65	1.31	100.00
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.90	1.90	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.99	-2.09	65.17
Naive Interpretation	Member

06 - Financial Health · Weak

Rating